Ticagrelor
Brand name: Brilinta
Rank #93 of 500 drugs by total cost
$195.8M
Total Cost
293,897
Total Claims
$195.8M
Total Cost
10,400
Prescribers
$666
Cost per Claim
37,944
Beneficiaries
450,417
30-Day Fills
$19K
Avg Cost/Provider
28
Avg Claims/Provider
About Ticagrelor
Ticagrelor (sold as Brilinta) was prescribed 293,897 times by 10,400 Medicare Part D providers in 2023, costing the program $195.8M. At $666 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 90 | Brexpiprazole (Rexulti) | $204.0M | 136,378 |
| 91 | Glatiramer Acetate (Copaxone) | $203.6M | 40,986 |
| 92 | Denosumab (Prolia) | $199.4M | 114,710 |
| 93 | Ticagrelor (Brilinta) | $195.8M | 293,897 |
| 94 | Lurasidone Hcl (Latuda) | $190.9M | 254,237 |
| 95 | Darolutamide (Nubeqa) | $188.8M | 14,375 |
| 96 | Fluticasone Propionate (Fluticasone Propionate) | $187.5M | 5,343,836 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology